Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 12—December 2011

Letter

Rift Valley and West Nile Virus Antibodies in Camels, North Africa

Mehdi El-Harrak, Raquel Martín-Folgar, Francisco Llorente, Paloma Fernández-Pacheco, Alejandro Brun, Jordi Figuerola, and Miguel Ángel Jiménez-ClaveroComments to Author 
Author affiliations: Biopharma, Rabat, Morocco (M. El-Harrak); Centro de Investigación en Sanidad Animal, Valdeolmos, Spain (R. Martín-Folgar, F. Llorente, P. Fernández-Pacheco, A. Brun, M.Á. Jiménez-Clavero); Estación Biológica de Doñana, Seville, Spain (J. Figuerola)

Main Article

Table

Results of testing of camels for virus antibodies, by location, age group, and sex of camels examined, North Africa, 2009*

Camel characteristic No. samples No. positive for antibody
RVFV WNV AHSV RVFV and WNV
Origin
Tata 2 0 0 0 0
Smara-Laayoune 58 13 20 0 11
Dakhla 40 2 9 0 1
Age group, y
<1 18 1 1 0 1
1–2 25 0 1 0 0
3–5 7 1 3 0 1
6–10 27 6 12 0 10
>10 23 7 12 0 0
Sex
M 71 10 15 0 7
F 29 5 14 0 5
Total 100 15 29 0 12

*RVFV, Rift Valley fever virus; WNV, West Nile virus; AHSV, African horse sickness virus.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO